$1.825
-0.081 (-4.45%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ENGN Prediction & Forecast by Similar Chart Analysis
Alphio's ENGN stock price prediction model matches the current enGene Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.84 (+0.61%). The 1-week path is $1.89 (+3.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy enGene Therapeutics Inc Stock?
enGene Holdings Inc is not a good buy right now due to significant financial losses and analyst downgrades. The current price is $1.825, and the company reported a net loss of $30.23 million for Q2 2026. The forward P/E ratio is 0, indicating no earnings expected in the near term, which raises concerns about its profitability and growth potential.
ENGN stock price ended at $1.83 on Friday, after losing -4.45%
enGene Therapeutics Inc (ENGN) last closed at $1.825, losing -4.45%. These facts feed the 1-day and 1-week ENGN price prediction above.
Forecast Drivers
enGene Therapeutics Inc (ENGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ENGN, ranked by similarity.
Seasonality analysis for ENGN
Historically the probability of a positive August return for ENGN is 0.00%. October offers the highest probability of a positive month at 52.17%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ENGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.66 | $3.49 | $4.22 | +91.50% |
| Sep 2026 | $3.56 | $4.16 | $4.93 | +127.87% |
| Oct 2026 | $3.10 | $3.73 | $3.81 | +104.39% |
| Nov 2026 | $3.22 | $3.38 | $4.04 | +85.35% |
| Dec 2026 | $3.67 | $4.26 | $4.68 | +133.68% |
In 2026, enGene Therapeutics Inc (ENGN) is projected to range from $2.66 to $4.93.
enGene Therapeutics Inc 2026 monthly forecast
In Aug 2026, enGene Therapeutics Inc is projected to average $3.49, with a low of $2.66 and high of $4.22.
In Sep 2026, enGene Therapeutics Inc is projected to average $4.16, with a low of $3.56 and high of $4.93.
In Oct 2026, enGene Therapeutics Inc is projected to average $3.73, with a low of $3.10 and high of $3.81.
In Nov 2026, enGene Therapeutics Inc is projected to average $3.38, with a low of $3.22 and high of $4.04.
In Dec 2026, enGene Therapeutics Inc is projected to average $4.26, with a low of $3.67 and high of $4.68.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。